R-BMD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-BMD, covering 2018-11-01 to 2018-11-01. Get the full timeline:
Most recent: Clinical Trial Update: R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial [Phase 2]